ArticleActa pharmacologica Sinica2017

Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway.

Ni Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.